Grant Pickering, CHIEF EXECUTIVE OFFICER at Vaxcyte, Inc. (PCVX), sold 4,356 shares at $92.06 ($401K) on 2024-12-09, disclosed to the SEC on 2024-12-10.
Scheduled sale ($401k) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $92.03 | 1,029 | $95K | 23.6% |
| 2 | $92.03 | 1,029 | $95K | 23.6% |
| 3 | $92.06 | 961 | $88K | 22.0% |
| 4 | $92.06 | 961 | $88K | 22.0% |
| 5 | $93.10 | 222 | $21K | 5.1% |
| 6 | $93.60 | 154 |
| $14K |
| 3.6% |
| Total | $92.15 avg | 4,356 | $401K | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $1.2M | — | Filing → |
| PCVX | SELL | 2024-12-03 | $2.8M | — | Filing → |
| PCVX | SELL | 2024-11-08 | $246K | — | Filing → |